Amina Zoubeidi, Ph.D.
Affiliations: | 2004 | Université de Montréal, Montréal, Canada |
Area:
BiochemistryGoogle:
"Amina Zoubeidi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Simone Chevalier | grad student | 2004 | Université de Montréal | |
| (Role de la proteine tyrosine kinase Fer dans le cancer de la prostate.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu S, Chai T, Garcia-Marques F, et al. (2024) UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas. Cell Reports. Medicine. 101381 |
| Kaarijärvi R, Kaljunen H, Nappi L, et al. (2024) DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications Biology. 7: 108 |
| Crowell PD, Giafaglione JM, Jones AE, et al. (2023) MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Cell Reports. 42: 113221 |
| Rawat C, Ben-Salem S, Singh N, et al. (2023) Prostate cancer progression relies on the mitotic kinase citron kinase. Cancer Research |
| Tabrizian N, Nouruzi S, Cui CJ, et al. (2023) ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer. Cell Reports. 42: 112937 |
| Habault J, Schneider JA, Ha S, et al. (2023) A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer. Molecular Cancer Therapeutics |
| Nouruzi S, Tabrizian N, Zoubeidi A. (2023) Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer. Endocrinology. 164 |
| Lelong EIJ, Khelifi G, Adjibade P, et al. (2022) Prostate cancer resistance leads to a global deregulation of translation factors and unconventional translation. Nar Cancer. 4: zcac034 |
| Sjöström M, Zhao SG, Levy S, et al. (2022) The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. Cancer Research. OF1-OF15 |
| Linder S, Hoogstraat M, Stelloo S, et al. (2022) Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence. Cancer Discovery |